-like dopamine receptor agonist (Ki
values are 0.7, 1.5, 9.0 and 165 nM for D2
receptors respectively) that also displays high affinity for several serotonin receptor subtypes (Ki
= 1.2 - 20.0 nM for 5-HT1A
). Inhibits secretion of prolactin and growth hormone and reverses levodopa-induced dyskinesias in Parkinsonian monkeys.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors:in vitro culture studies.
Eguchi et al.
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists.
Kvernmo et al.
Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys.
Hadj Tahar et al.
The citations listed below are publications that use Tocris products. Selected citations for Cabergoline include:
Showing Results 1 - 2 of 2